Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival

被引:32
作者
Aleksic, Ilija [1 ]
Rais-Bahrami, Soroush [3 ,4 ]
Daugherty, Michael [2 ]
Agarwal, Piyush K. [5 ]
Vourganti, Srinivas [2 ]
Bratslavsky, Gennady [2 ]
机构
[1] Albany Med Ctr, Div Urol, Albany, CA USA
[2] Upstate Med Univ, Dept Urol, Syracuse, NY USA
[3] Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA
[4] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA
[5] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
关键词
Gender influence; Surveillance; Epidemiology; and End Results; survival; urethral carcinoma;
D O I
10.4103/UA.UA_136_17
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Primary urethral carcinoma (PUC) is rare, accounting for < 1% of genitourinary malignancies. Current knowledge regarding is founded upon tertiary care centers reporting their experiences. We aim to identify factors predictive of outcomes using a nationwide registry database. Materials and Methods: The Surveillance, Epidemiology, and End Results-18 registries database was queried for cases of PUC ranging between 2004 and 2010. To identify PUC cases, ICD-O site code C68.0 was used as a filter, hence identifying PUC with histologic subtypes including urothelial carcinoma (UC), squamous cell carcinoma (SCC), and adenocarcinoma (AC). Tumor characteristics were compared using log-rank analysis, and survival outcomes were compared using Cox proportional hazards models. Results: A total of 419 PUC cases were identified, 250 (59.7%) male and 169 (40.3%) female patients. The most common histology in men was UC (134, 53.6%), followed by SCC (87, 34.8%) and AC (29, 11.6%). The most common histology in women was AC (79, 46.7%), followed by SCC (43, 25.4%) and UC (42, 24.9%). Log-rank analysis illustrated significant difference in cancer-specific survival (CSS) for T-stage, N-stage, M-stage, and stage of PUC with all histological variants combined (P < 0.001). Multivariate Cox proportional hazards model demonstrated that stage and age were significant for survival, with a risk ratio of 1.033 (95% confidence interval [CI], 1.020-1.046)/year of increased age (P < 0.001) and 3.71 (95% CI, 2.72-5.05) for patients with regional or distant spread. Conclusions: Knowledge of patient and tumor characteristics that influences survival is paramount in dictating management. The present study illustrates that age and stage are factors significantly associated with CSS in PUC.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 25 条
  • [1] PRIMARY SQUAMOUS-CELL CARCINOMA OF ANTERIOR MALE URETHRA
    ANDERSON, KA
    MCANINCH, JW
    [J]. UROLOGY, 1984, 23 (02) : 134 - 140
  • [2] PRIMARY URETHRAL NEOPLASMS - REVIEW OF 30 CASES
    BOLDUAN, JP
    FARAH, RN
    [J]. JOURNAL OF UROLOGY, 1981, 125 (02) : 198 - 200
  • [3] Prognostic Factors and Outcomes After Definitive Treatment of Female Urethral Cancer: A Population-based Analysis
    Champ, Colin E.
    Hegarty, Sarah E.
    Shen, Xinglei
    Mishra, Mark V.
    Dicker, Adam P.
    Trabulsi, Edouard J.
    Lallas, Costas D.
    Gomella, Leonard G.
    Hyslop, Terry
    Showalter, Timothy N.
    [J]. UROLOGY, 2012, 80 (02) : 374 - 381
  • [4] Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
    Chen, Chien-Hung
    Chang, Ting-Tsung
    Cheng, Ken-Sheng
    Su, Wei-Wen
    Yang, Sheng-Shun
    Lin, Hans Hsienhong
    Wu, Shun-Sheng
    Lee, Chuan-Mo
    Changchien, Chi-Sin
    Chen, Chien-Jen
    Sheu, Jin-Chuan
    Chen, Ding-Shinn
    Lu, Sheng-Nan
    [J]. LIVER INTERNATIONAL, 2006, 26 (07) : 766 - 773
  • [5] Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: Results of a contemporary cystectomy series from M. D. Anderson Cancer Center
    Chen, ME
    Pisters, LL
    Malpica, A
    Pettaway, CA
    Dinney, CP
    [J]. JOURNAL OF UROLOGY, 1997, 157 (06) : 2120 - 2123
  • [6] Male urethral carcinoma: Analysis of treatment outcome
    Dalbagni, G
    Zhang, ZF
    Lacombe, L
    Herr, HW
    [J]. UROLOGY, 1999, 53 (06) : 1126 - 1132
  • [7] Management of advanced primary urethral carcinomas
    Dayyani, Farshid
    Hoffman, Karen
    Eifel, Patricia
    Guo, Charles
    Vikram, Raghu
    Pagliaro, Lance C.
    Pettaway, Curtis
    [J]. BJU INTERNATIONAL, 2014, 114 (01) : 25 - 31
  • [8] Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists
    Dayyani, Farshid
    Pettaway, Curtis A.
    Kamat, Ashish M.
    Munsell, Mark F.
    Sircar, Kanishka
    Pagliaro, Lance C.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1171 - 1177
  • [9] Multimodal management of primary adenocarcinoma of the female urethra: About four cases
    Deberne, M.
    Timsit, M. -O.
    Verkarre, V.
    Eiss, D.
    Kreps, S.
    Dupont, S.
    Housset, M.
    [J]. CANCER RADIOTHERAPIE, 2016, 20 (03): : 169 - 175
  • [10] Surgical treatment for local control of female urethral carcinoma
    DiMarco, DS
    DiMarco, CS
    Zincke, H
    Webb, MJ
    Bass, SE
    Slezak, JM
    Lightner, DJ
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 404 - 409